Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Behavioral Diagnostics
Iowa City, Iowa, United States
- Ownership
- Private
- Employees
- ~3
- Development stage
- Other
01
Overview
Behavioral Diagnostics has developed and commercialized epigenetic diagnostic tests to detect and quantify tobacco and alcohol use, and to assess lung cancer risk, using blood or saliva samples. Their tests demonstrate high sensitivity and specificity for usage detection and show peer-reviewed validation in clinical studies[1][3].
- Therapeutic areas
- OncologyPsychiatry
- Modalities
- Diagnostic testDevice
- Industry
- Molecular Diagnostics
02
Partnerships
Integrated DNA Technologies (IDT)IBI Scientific
Beyond the preview
Go deeper on Behavioral Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Behavioral Diagnostics.